1 i) secretion of pre-formed IL-8, and Charcot Leyden crystal (CLC) formation, which was most evident i

2                                      Charcot-Leyden crystal (CLC) protein, initially reported to poss

3  eosinophil-rich diseases in humans (Charcot-Leyden crystals).

4 in the accumulation of intracellular Charcot-Leyden-like crystals in alveolar macrophages by wk 4 and

5  age that included the appearance of Charcot-Leyden crystals.

6                      The presence of Charcot-Leyden-like crystals in airway macrophages and the incre

7 s cell metaplasia, the deposition of Charcot-Leyden-like crystals, airway fibrosis, eotaxin productio

8  and acidic mucus, the deposition of Charcot-Leyden-like crystals, and subepithelial airway fibrosis

9                                  The Charcot-Leyden crystal (CLC) protein, or eosinophil lysophosphol

10 ers for emerging electrical treatments: with Leyden jars, with galvanic and electromagnetic machines,